134.76
Overview
News
Price History
Option Chain
Financials
Why CLX Down?
Discussions
Forecast
Stock Split
Dividend History
Clorox Co stock is traded at $134.76, with a volume of 1.93M.
It is down -2.21% in the last 24 hours and down -3.62% over the past month.
Since its start more than 100 years ago, Clorox has expanded to operate in a variety of consumer products categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
See More
Previous Close:
$137.81
Open:
$137.84
24h Volume:
1.93M
Relative Volume:
1.31
Market Cap:
$17.14B
Revenue:
$7.47B
Net Income/Loss:
$357.00M
P/E Ratio:
46.95
EPS:
2.87
Net Cash Flow:
$669.00M
1W Performance:
-3.11%
1M Performance:
-3.62%
6M Performance:
-18.41%
1Y Performance:
-4.80%
Clorox Co Stock (CLX) Company Profile
Name
Clorox Co
Sector
Industry
Phone
(510) 271-7000
Address
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CLX
Clorox Co
|
134.76 | 17.14B | 7.47B | 357.00M | 669.00M | 2.87 |
![]()
PG
Procter Gamble Co
|
157.66 | 376.35B | 83.93B | 15.50B | 15.03B | 6.30 |
![]()
UL
Unilever Plc Adr
|
62.50 | 155.93B | 65.10B | 6.16B | 0 | 2.4569 |
![]()
CL
Colgate Palmolive Co
|
89.81 | 73.33B | 19.95B | 2.90B | 3.47B | 3.54 |
![]()
KVUE
Kenvue Inc
|
24.44 | 46.01B | 15.46B | 1.03B | 1.34B | 0.53 |
![]()
KMB
Kimberly Clark Corp
|
133.05 | 43.25B | 19.75B | 2.47B | 2.39B | 7.34 |
Clorox Co Stock (CLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Nov-06-24 | Upgrade | TD Cowen | Sell → Hold |
Oct-01-24 | Upgrade | Jefferies | Hold → Buy |
Jul-23-24 | Initiated | TD Cowen | Sell |
Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
Apr-02-24 | Downgrade | Citigroup | Buy → Neutral |
Mar-26-24 | Upgrade | Jefferies | Underperform → Hold |
Mar-01-24 | Resumed | Goldman | Sell |
Feb-05-24 | Downgrade | DA Davidson | Buy → Neutral |
Dec-15-23 | Upgrade | BofA Securities | Underperform → Neutral |
Nov-22-23 | Upgrade | JP Morgan | Underweight → Neutral |
Nov-13-23 | Initiated | Jefferies | Underperform |
Nov-06-23 | Upgrade | UBS | Sell → Neutral |
Nov-02-23 | Upgrade | Citigroup | Neutral → Buy |
Oct-12-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
Oct-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
Oct-02-23 | Upgrade | DA Davidson | Neutral → Buy |
Sep-22-23 | Initiated | HSBC Securities | Hold |
Aug-03-23 | Upgrade | Atlantic Equities | Underweight → Neutral |
Feb-17-23 | Initiated | Citigroup | Neutral |
Oct-18-22 | Initiated | Evercore ISI | Underperform |
Oct-17-22 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Sep-14-22 | Resumed | BofA Securities | Underperform |
Jul-13-22 | Initiated | Raymond James | Outperform |
Feb-04-22 | Downgrade | Atlantic Equities | Neutral → Underweight |
Feb-04-22 | Reiterated | Deutsche Bank | Hold |
Feb-04-22 | Reiterated | JP Morgan | Underweight |
Feb-04-22 | Reiterated | Morgan Stanley | Underweight |
Feb-04-22 | Reiterated | UBS | Sell |
Feb-04-22 | Reiterated | Wells Fargo | Underweight |
Feb-02-22 | Downgrade | Bernstein | Mkt Perform → Underperform |
Jan-26-22 | Downgrade | Credit Suisse | Neutral → Underperform |
Nov-02-21 | Reiterated | DA Davidson | Neutral |
Nov-02-21 | Reiterated | Deutsche Bank | Hold |
Nov-02-21 | Downgrade | JP Morgan | Neutral → Underweight |
Nov-02-21 | Reiterated | Wells Fargo | Underweight |
Sep-03-21 | Downgrade | Argus | Buy → Hold |
Aug-04-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
Aug-04-21 | Reiterated | Citigroup | Buy |
Aug-04-21 | Reiterated | Credit Suisse | Neutral |
Aug-04-21 | Reiterated | Deutsche Bank | Hold |
Aug-04-21 | Reiterated | Morgan Stanley | Underweight |
Aug-04-21 | Reiterated | RBC Capital Mkts | Sector Perform |
Aug-04-21 | Reiterated | UBS | Sell |
Aug-04-21 | Reiterated | Wells Fargo | Underweight |
Jun-24-21 | Initiated | UBS | Sell |
May-03-21 | Downgrade | Wells Fargo | Overweight → Underweight |
Mar-18-21 | Downgrade | DA Davidson | Buy → Neutral |
Feb-19-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
Jan-20-21 | Initiated | Bernstein | Mkt Perform |
Dec-14-20 | Upgrade | Citigroup | Neutral → Buy |
Dec-08-20 | Initiated | Wells Fargo | Overweight |
Oct-16-20 | Downgrade | JP Morgan | Overweight → Neutral |
Jun-30-20 | Initiated | DA Davidson | Buy |
Mar-19-20 | Downgrade | Credit Suisse | Outperform → Neutral |
Mar-16-20 | Upgrade | JP Morgan | Underweight → Overweight |
Mar-09-20 | Upgrade | Argus | Hold → Buy |
Oct-03-19 | Reiterated | BofA/Merrill | Neutral |
Sep-23-19 | Downgrade | Barclays | Equal Weight → Underweight |
May-20-19 | Downgrade | Argus | Buy → Hold |
May-02-19 | Reiterated | BofA/Merrill | Neutral |
May-02-19 | Upgrade | Deutsche Bank | Sell → Hold |
Apr-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
Mar-07-19 | Initiated | Credit Suisse | Outperform |
Dec-06-18 | Reiterated | BofA/Merrill | Neutral |
Sep-25-18 | Upgrade | Argus | Hold → Buy |
Jul-18-18 | Downgrade | Goldman | Neutral → Sell |
Apr-19-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Feb-08-18 | Downgrade | Argus | Buy → Hold |
Jan-04-18 | Upgrade | BofA/Merrill | Underperform → Neutral |
View All
Clorox Co Stock (CLX) Latest News
28,869 Shares in The Clorox Company (NYSE:CLX) Acquired by Algert Global LLC - MarketBeat
Axa S.A. Purchases 48,524 Shares of The Clorox Company (NYSE:CLX) - MarketBeat
The Clorox Company (CLX): Among the Best High-Yield Dividend Stocks for 2025 and Beyond - Insider Monkey
5,441 Shares in The Clorox Company (NYSE:CLX) Acquired by Bridgefront Capital LLC - MarketBeat
The Clorox Company (NYSE:CLX) Shares Acquired by Comerica Bank - MarketBeat
Clorox Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - simplywall.st
Crestline Management LP Buys New Stake in The Clorox Company (NYSE:CLX) - MarketBeat
Brokerages Set The Clorox Company (NYSE:CLX) PT at $152.77 - MarketBeat
Schonfeld Strategic Advisors LLC Sells 13,117 Shares of The Clorox Company (NYSE:CLX) - MarketBeat
Clorox (CLX) Secures New Agreement with Vizient to Enhance Healthcare Solutions | CLX Stock News - GuruFocus
CloroxPro Announces New Agreement with Vizient to Supply Range of Cleaning and Disinfecting Products - PR Newswire
7,881 Shares in The Clorox Company (NYSE:CLX) Bought by Advanced Portfolio Management LLC - MarketBeat
The Clorox Company (NYSE:CLX) Q3 2025 Earnings Call Transcript - Insider Monkey
Clorox (NYSE:CLX) Posts Earnings Results, Misses Estimates By $0.12 EPS - MarketBeat
TD Cowen Adjusts Price Target on Clorox to $135 From $145, Maintains Hold Rating - marketscreener.com
Clorox CEO sees shoppers ditching bleach for iPhones ahead of tariffs. Wall Street is skeptical - The Business Journals
Barclays Adjusts Price Target for Clorox (CLX) to $129 | CLX Stock News - GuruFocus
Clorox (CLX) Faces Lower Price Target Amidst Weak Performance | - GuruFocus
Clorox (CLX) Faces Lower Price Target Amidst Weak Performance | CLX Stock News - GuruFocus
Clorox stock target cut to $140 by Evercore ISI on sales miss - Investing.com Nigeria
Clorox Reports Q3 Fiscal Year 2025 Results, Updates Outlook - ADVFN
Jefferies cuts Clorox stock price target to $167, maintains Buy rating - Investing.com Nigeria
Why Clorox Stock Sank Today - The Motley Fool
Jim Cramer on Clorox (CLX): “Clorox Is Cramer’s Bull Market Gauge” - Insider Monkey
Clorox (CLX) Faces Challenges Amid Uncertain Economic Outlook - GuruFocus
HSBC Cuts Price Target on Clorox to $157 From $163 - marketscreener.com
Clorox Q3 Earnings & Sales Miss Estimates, Margin Expands, Stock Down - Yahoo Finance
Clorox (CLX) Price Target Lowered by Morgan Stanley to $150 | CLX Stock News - GuruFocus
Clorox F3Q results miss, Raymond James maintains Market Perform - Investing.com Australia
Clorox Stock Crumbles Following Earnings Miss - Schaeffer's Investment Research
Clorox (CLX) Price Target Reduced Amidst Sales Challenges | CLX Stock News - GuruFocus
Clorox (CLX) Price Target Lowered by Wells Fargo | CLX Stock News - GuruFocus
Clorox Analysts Slash Their Forecasts After Downbeat Results - Benzinga
CLX Stock Update: JP Morgan Adjusts Clorox Price Target | CLX St - GuruFocus
Clorox (CLX) Sees Price Target Reduction Amid Earnings Concerns - GuruFocus
Sector Update: Consumer Stocks Mixed Premarket Tuesday - marketscreener.com
Tough macro scenario to weigh on Clorox's sales in the near term; shares fall (CLX:NYSE) - Seeking Alpha
CLX Stock Update: JP Morgan Adjusts Clorox Price Target | CLX Stock News - GuruFocus
Clorox’s Financial Outlook: Hold Rating Amid Sales Guidance Revision and Market Challenges - TipRanks
Clorox (CLX) Faces Price Target Reduction Amid Earnings Forecast Adjustments | CLX Stock News - GuruFocus
Barclays Adjusts Price Target on Clorox Company to $129 From $134 - marketscreener.com
Clorox (CLX) Faces Price Target Cut by JPMorgan Analyst | CLX St - GuruFocus
Clorox F3Q results miss, Raymond James maintains Market Perform By Investing.com - Investing.com UK
Wells Fargo cuts Clorox stock price target to $142 from $145 - Investing.com Canada
JPMorgan cuts Clorox stock price target to $144 from $151 - Investing.com
Deutsche Bank Adjusts Price Target on Clorox to $146 From $150, Maintains Hold Rating - marketscreener.com
Clorox (CLX) Price Target Revised Amid Growth Concerns | CLX Stock News - GuruFocus
Goldman Sachs cuts Clorox price target to $134, maintains Sell rating - Investing.com UK
Earnings call transcript: Clorox Q1 2025 misses EPS forecast, stock dips - Investing.com Nigeria
Clorox Co (CLX) Q3 2025 Earnings Call Highlights: Resilient Margins Amid Challenging Market ... - Yahoo Finance
Clorox Co (CLX) Q3 2025 Earnings Call Highlights: Resilient Marg - GuruFocus
Clorox Co Stock (CLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):